Jae Sook Ahn

Ontology type: schema:Person     

Person Info


Jae Sook



Publications in SciGraph latest 50 shown

  • 2019-12 Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma in BMC CANCER
  • 2019-01 18F-FDG PET/CT is useful for determining survival outcomes of patients with multiple myeloma classified as stage II and III with the Revised International Staging System in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-12-16 HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia in LEUKEMIA
  • 2018-12 Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL) in BMC CANCER
  • 2018-12 Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts in ANNALS OF HEMATOLOGY
  • 2018-06 Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patients in ANNALS OF HEMATOLOGY
  • 2018-02 Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies in BONE MARROW TRANSPLANTATION
  • 2017-09 The clonal origins of leukemic progression of myelodysplasia in LEUKEMIA
  • 2016-12 Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen in BMC CANCER
  • 2016-11 Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes in ANNALS OF HEMATOLOGY
  • 2016-10 Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression in ANNALS OF HEMATOLOGY
  • 2016-09 Naïve CD8+ T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment in SCIENTIFIC REPORTS
  • 2016-08 Cytogenetic profiles of 2806 patients with acute myeloid leukemia—a retrospective multicenter nationwide study in ANNALS OF HEMATOLOGY
  • 2016-03 Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML in ANNALS OF HEMATOLOGY
  • 2016-02 Clonal dynamics in a single AML case tracked for 9 years reveals the complexity of leukemia progression in LEUKEMIA
  • 2016-01 Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant in ANNALS OF HEMATOLOGY
  • 2016-01 Erratum to: Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant in ANNALS OF HEMATOLOGY
  • 2016-01 Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen in ANNALS OF HEMATOLOGY
  • 2015-12 Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma in BMC CANCER
  • 2015-12 The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts in BMC CANCER
  • 2015-10 Single monosomy as a relatively better survival factor in acute myeloid leukemia patients with monosomal karyotype in BLOOD CANCER JOURNAL
  • 2014-11 Effect of levofloxacin prophylaxis for prevention of severe infections in multiple myeloma patients receiving bortezomib-containing regimens in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2014-05 Decreased body mass index is associated with poor prognosis in patients with multiple myeloma in ANNALS OF HEMATOLOGY
  • 2014-05 Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromes in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2013-06 Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial in ANNALS OF HEMATOLOGY
  • 2013-04 Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era in ANNALS OF HEMATOLOGY
  • 2013-03 Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2013-01 Efficacy of stem cell mobilization in patients with newly diagnosed multiple myeloma after a CTD (cyclophosphamide, thalidomide, and dexamethasone) regimen in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2012-12 Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL) in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2012-07 A comparison of bortezomib, cyclophosphamide, and dexamethasone (Vel-CD) chemotherapy without and with thalidomide (Vel-CTD) for the treatment of relapsed or refractory multiple myeloma in ANNALS OF HEMATOLOGY
  • 2012-01 Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy in CELLULAR & MOLECULAR IMMUNOLOGY
  • 2011-12 Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins in ANNALS OF HEMATOLOGY
  • 2011-07 Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists in CELLULAR & MOLECULAR IMMUNOLOGY
  • 2010-10 Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset in BONE MARROW TRANSPLANTATION
  • 2010-08 Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells in ANNALS OF HEMATOLOGY
  • 2010-05 Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study in ANNALS OF HEMATOLOGY
  • 2010-01 Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine in ANNALS OF HEMATOLOGY
  • 2009-07 Polymyositis and myocarditis after donor lymphocyte infusion in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2009-05 The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin’s lymphoma in ANNALS OF HEMATOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.411602.0", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "https://www.grid.ac/institutes/grid.14005.30", 
            "type": "Organization"
        "familyName": "Ahn", 
        "givenName": "Jae Sook", 
        "id": "sg:person.01017560023.88", 
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:47", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_528.json", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01017560023.88'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01017560023.88'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01017560023.88'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01017560023.88'


    Preview window. Press ESC to close (or click here)